Form D · Biotechnology

PROXIMITY THERAPEUTICS, INC.

Cambridge, MA · CIK 0001863177

Offering snapshot reported Jan 4, 2023 · SEC filing

Reported sold
$11M
Offering amount: $11M
Investors reported
9
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 4, 2021
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$5.5M$11MMay 19, 2021: $1,999,998.00May 19, 2021Jan 4, 2023: $11,000,001.00Jan 4, 2023

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,999,998 → $11,000,001
  • Reported investors3 → 9

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 4, 2023Amendment$11,000,001$9,000,003vs May 19, 20219SEC filing
May 19, 2021Initial$1,999,998No comparison3SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-399956

Source: Form D, filed Jan 4, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Guillermo Elias Executive
Julius Knowles Director
Steven W. Tregay Director, Executive, Promoter

Issuer details

Industry: Biotechnology (See others in industry)

Address:
139 Main Street
Cambridge, MA, 02142